Patients at greatest risk of dying from pulmonary arterial hypertension (PAH) may be identified through cardiac magnetic resonance imaging (MRI) and the information the noninvasive scan provides about the functional level of the heart’s right ventricle, according to research presented at ATS 2019.
An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target,
Patients with severe eosinophilic asthma, who participated in three different Phase 3 trials of benralizumab (brand name Fasenra) and then enrolled in a long-term trial of the drug’s efficacy and safety, continued to experience fewer exacerbations and improved pulmonary function and quality of life
Progressive massive fibrosis (PMF), the worst form of black lung disease, is rising among coal miners, but the reasons for this trend remain unclear, according to research presented at ATS 2019.
Black lung disease and other non-malignant respiratory diseases appear to account for a greater proportion of deaths in younger generations of coal miners than in older generations of miners, according to research presented at ATS 2019.
In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH), according to research presented at ATS 2019.
Bacterial pneumonia appears to be linked to ongoing breathing problems in previously healthy infants who were hospitalized in a pediatric intensive care unit for acute respiratory failure, according to research presented at ATS 2019.
Spyridon Fortis, MD, of the University of Iowa has been awarded The ATS Foundation/Fisher & Paykel Healthcare Research Award in Respiratory Support with Nasal High Flow (NHF) in Patients with COPD. The $100,000 award will help fund Dr. Fortis’ study, “The Effect of Heated, Humidified High-Flow Air in COPD Patients with Chronic Bronchitis.”
The ATS Foundation is pleased to announce that Shashi Kant, PhD, of Baylor Research Institute, has been awarded the ATS Foundation/Insmed Research Award in Nontuberculous Mycobacterial (NTM) Lung Disease. The award will provide one year of support in the amount of $50,000 to help fund Dr. Kant’s research, “Novel Short Course Chemotherapy for Treatment of M. kansasii.”
On World Asthma Day, the American Thoracic Society joins the Global Initiative for Asthma (GINA) and other founding members of the Forum of International Respiratory Societies (FIRS) in recognizing this year’s theme: “STOP for asthma.” FIRS calls on global health care providers to STOP for asthma and evaluate symptoms, test response to therapy, observe and assess, and finally proceed to adjust treatment.
The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
A short video describing the potential benefits and risks of low-dose CT screening for lung cancer in addition to an informational brochure increased patients’ knowledge and reduced conflicted feelings about whether to undergo the scan more than the informational brochure alone, according to a randomized, controlled trial published online in the Annals of the American Thoracic Society.
Air pollution from diesel engines may worsen allergy-induced lung impairment more when tiny particles are filtered from the exhaust than when they are not, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Paul Andrew Reyfman, MD, MS of Northwestern University has been awarded the ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Research Fellowship in idiopathic pulmonary fibrosis. The $100,000 award will help fund Dr. Reyfman’s research, “Single Cell Transcriptomic Analysis of Pulmonary Fibrosis.”
Landon W. Locke, PhD, of Ohio State University has been awarded the ATS Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis. The $80,000 award will help fund Dr. Locke’s study, “Abnormally Sustained M2-like Macrophage Polarization Drives Sarcoidosis Granulomas.”
Dietary intake of two fatty acids, omega-3 and omega-6, may have opposite effects on the severity of asthma in children and may also play opposite roles in modifying their response to indoor air pollution, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
On World TB Day, the American Thoracic Society, along with our partners in the Forum of International Respiratory Societies (FIRS), urges governments to leverage the success of the first-ever United Nation (UN) High-Level Meeting (HLM) in the fight against tuberculosis, held in 2018. The meeting produced a UN political declaration on TB and the endorsement at the highest level to take the necessary steps to end the TB epidemic.
Critically ill patients are more likely to be successfully weaned from a mechanical ventilator, or breathing machine, if they have higher levels of wakefulness and both their right and left brains experience the same depth of sleep, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The ATS Foundation has announced that 14 researchers have been awarded one-year, $40,000 Unrestricted Research Grants to advance pulmonary, critical care and sleep medicine.
Adults with obstructive sleep apnea (OSA) who experience excessive sleepiness while awake appear to be at far greater risk for cardiovascular diseases than those without excessive daytime sleepiness, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Compared to Mexican American children, Puerto Rican children were more likely to have poor or decreasing use of inhaled medication needed to control their asthma, according to new research published online in the Annals of the American Thoracic Society.
The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society’s American Journal of Respiratory and Critical Care Medicine.
Fish oil does not appear to improve asthma control in adolescents and young adults with uncontrolled asthma who are overweight or obese, according to new research published online in the Annals of the American Thoracic Society.
As levels of ozone and fine particulate pollution (PM2.5) rise, more patients end up in the ER with breathing problems, according to the largest U.S. study of air pollution and respiratory emergency room visits of patients of all ages. The study was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The ill effects of air pollution may literally be causing some people to lose sleep, according to new research published online in the Annals of the American Thoracic Society.
They say everything is bigger in Texas and this year Dallas is hosting the ATS 2019 International Conference, the biggest gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine.
In a letter to EPA Acting Administrator Andrew Wheeler members of the scientific community expressed concern about the agency’s decision to dissolve pollutant-specific advisory panels, including one charged with setting the National Ambient Air Quality Standard or NAAQS for airborne particulate matter or PM.
Vitamin C may reduce the harm done to lungs in infants born to mothers who smoke during their pregnancy, according to a randomized, controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
In an era of personalized medicine, physicians treating patients with chronic obstructive pulmonary disease (COPD) should consider individualized therapy depending on disease severity and the cost and availability of medications. However, some physicians may not be as informed as they would like to be about which inhalation devices for COPD are best for which patients, according to a survey designed by American Thoracic Society (ATS) clinicians and scientists and conducted by Harris Poll, which was published in the July issue of Respiratory Care.
Middle-aged adults with lung disease may be at greater risk of developing dementia or cognitive impairment later in life, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
In response to today’s shocking data from the CDC documenting a 78 percent increase e-cigarette use among high schoolers and a 48 percent increase among middle schoolers, the FDA is finally taking concrete action to regulate tobacco products. The American Thoracic Society strongly supports the initial announcement, but more concrete action is needed.
Only a tiny fraction of patients hospitalized for COPD, or chronic obstructive pulmonary disease, participate in a pulmonary rehabilitation program following hospitalization, even though such programs are recommended and Medicare covers their cost, according to new research published online in the Annals of the American Thoracic Society.
The American Thoracic Society is gravely concerned and disappointed in the FDA’s decision to approve over the counter epinephrine (Primatene Mist HFA) for consumer use to treat asthma. The ATS is a medical professional society dedicated to the prevention, detection, treatment and research of pulmonary disease, critical care illness and sleep disordered breathing. Our members are experts in the diagnosis and management of asthma and have published several clinical practice guidelines for the treatment of asthma. It is with our extensive clinical expertise in the treatment of asthma and our concern for the patients that we oppose the FDA’s decision.
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Whether they are smokers or not, people living in poor, rural areas of the United States are more likely to have COPD, or chronic obstructive pulmonary disease, according to research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The American Thoracic Society and the American Lung Association’s LUNG FORCE initiative have launched a new website and online toolkit to help medical institutions implement and manage a lung cancer screening program.
How long a person with obstructive sleep apnea (OSA) stops breathing may be a better predictor of mortality risk from OSA than the number of times they stop breathing, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Long-term use of benzodiazepine medications in patients with chronic obstructive pulmonary disease, or COPD, as well as posttraumatic stress disorder (PTSD) may lead to increased suicide risk, according to a study published online in the Annals of the American Thoracic Society.
A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology. The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Burning wood or coal to cook food is associated with increased risk of hospitalization or dying from respiratory diseases, according to new research conducted in China and published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The American Thoracic Society (ATS) joins the World Health Organization in calling for robust global political commitments, including funding, to halt the TB pandemic, following the release of the WHO Global Tuberculosis Report 2018 today. This important report describes in detail the global morbidity and mortality burden of TB and provides critical context for the first-ever United Nations High Level Meeting on Tuberculosis on Sept 26, 2018.
A new guideline focused on the role of weight management in treating adult obstructive sleep apnea (OSA) has been published online by the American Thoracic Society in the Sept. 15 American Journal of Respiratory and Critical Care Medicine.
Sept. 14, 2018─Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria (NTM) lung infections, according to new research published online in the Annals of the American Thoracic Society.
Today, the American Thoracic Society joined U.S. Senators Sherrod Brown (D-OH) and Todd Young (R-IN) and other senators in calling on the Trump administration to show leadership in global TB elimination efforts. Senators Brown and Young sent a bipartisan letter to President Trump urging the Administration to provide robust commitments, including for TB control and research and development programs, during the United Nations General Assembly’s (UNGA) High-Level Meeting on Tuberculosis.
A New York State requirement that all hospitals report compliance with protocols to treat severe sepsis and septic shock appears to improve care and reduce mortality from one of the most common causes of death in those who are critically ill, according to a new study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right